Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2001
07/10/2001US6258935 Amino acid sequence of lymphocyte specific interferon regulatory factor, a type of transcription factor; recombinant expression of this polypeptide
07/10/2001US6258929 Amino acid sequence of protein which binds presenilin 1; alzheimer's disease
07/10/2001US6258599 Compositions and methods for treating viral infections
07/10/2001US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome
07/10/2001US6258579 I-kappa-b kinase signalsome capable of specifically phosphorylating i-kappa-b-alpha and i-kappa-b-beta; antiinflammatory agents; anticarcinogenic agents; viricides; treatment of autoimmune and nervous system disorders
07/10/2001US6258564 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method the hybirdomas and antigen proteins recognized by the antibodies
07/10/2001US6258562 Human antibodies that bind human TNFα
07/10/2001US6258560 Using cell having nucleic acid encoding a phage lysozyme and gene t product, second nucleic acid encoding a dna-digesting protein linked to a signal sequence for secretion, and third nucleic acid encoding heterologous polypeptide
07/10/2001US6258547 Nucleic acid encoding amp-activated protein kinase
07/10/2001US6258529 Nucleotide sequences coding antibody; for use in diagnosis and human therapy
07/10/2001US6258364 Isolated carbohydrate epitope; immunocontraceptive vaccines; semen detection; medical diagnosis; antifertility agents
07/10/2001US6258363 Test kits
07/10/2001US6258360 Benzoate conjugates; antitumor agents
07/10/2001US6258359 Antiulcer agents, gastrointestinal disorders
07/10/2001US6258358 Targeted immunostimulation with bispecific reagents
07/10/2001US6258353 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
07/10/2001CA2089395C Monoclonal antibodies for detecting water treatment polymers
07/10/2001CA2060666C Antigenic epitopes present on membrane-bound but not secreted iga
07/10/2001CA2032505C Coat transmembrane glycoprotein antigens of a hiv-2 type human retrovirus and antigens sharing immunological similarities
07/05/2001WO2001048485A2 Selecting library members capable of binding to epitopes
07/05/2001WO2001048482A1 Interaction between cd14 and hbv components
07/05/2001WO2001048214A2 METHOD FOR PRODUCING 6-0-α-D-GLUCOPYRANOSYL-D-SORBITE
07/05/2001WO2001048209A2 Genes identified as required for proliferation of e. coli
07/05/2001WO2001048208A2 Streptococcus pyogenes virulence genes and proteins and their use
07/05/2001WO2001048203A1 Novel protein and dna thereof
07/05/2001WO2001048163A2 Dioxygenases catalyzing the asymetric cleavage of beta-carotene
07/05/2001WO2001048162A2 Method for the production of vitamin a
07/05/2001WO2001048161A2 Human heparanase-related polypeptide and nucleic acid
07/05/2001WO2001048150A1 Cells capable of differentiating into heart muscle cells
07/05/2001WO2001048149A1 Adult bone marrow-origin cell capable of differentiating into heart muscle cell
07/05/2001WO2001048020A1 Composition for inhibiting macrophage activity
07/05/2001WO2001048019A1 Method of diagnosing mesangium proliferative nephritis in rat
07/05/2001WO2001048018A1 Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens
07/05/2001WO2001048017A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
07/05/2001WO2001047961A1 P. gingivalis antigenic composition
07/05/2001WO2001047959A2 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
07/05/2001WO2001047953A2 Antibodies against plasma cells
07/05/2001WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof
07/05/2001WO2001047555A1 Treating cancers associated with overexpression of class i family of receptor tyrosine kinases
07/05/2001WO2001047554A1 Stable antibody compositions and injection preparations
07/05/2001WO2001047543A2 Activation and inhibition of the immune system
07/05/2001WO2001047533A2 INHIBITION OF GSK-3$g(b)
07/05/2001WO2001047518A1 Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant emap ii
07/05/2001WO2001012777A3 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
07/05/2001WO2001002563A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
07/05/2001WO2001002005A3 Treatment of dentritic cells for induction of immune tolerance
07/05/2001WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
07/05/2001WO2001000822A3 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein
07/05/2001WO2000073348A3 Methods and compositions for inhibiting neoplastic cell growth
07/05/2001WO2000071679A3 Human oxidoreductase proteins
07/05/2001WO2000070046A3 Secreted polypeptides and corresponding polynucleotides
07/05/2001WO2000061622A3 Genes associated with diseases of the kidney
07/05/2001WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
07/05/2001WO2000059942A3 Human obesity protein binding protrein-2 homolog and uses thereof
07/05/2001WO2000034483A9 Compounds and methods for treatment and diagnosis of chlamydial infection
07/05/2001WO2000023114A9 Polymer conjugates of interferon beta- 1a and their uses
07/05/2001WO2000018799A9 Artemin, a novel neurotrophic factor
07/05/2001WO2000017356A9 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
07/05/2001US20010007155 Producing transgenic potato plant cells and plants synthesizing starch with modified viscosity and phosphate content
07/05/2001US20010007022 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free N-procalcitonin; used as an in vitro or in vivo diagnostic agent
07/05/2001US20010007021 Monoclonal antibody, antigen-binding region of which competitively inhibits immunospecific binding of monoclonal antibody produced by hybridoma R7.6.2 having ATCC accession number 13 13 13 13 to target epitope; use in organ transplants
07/05/2001US20010007020 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
07/05/2001US20010007019 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing
07/05/2001US20010007017 For preventing AIDS or slowing down its progression
07/05/2001US20010006947 Methods of administering adenoviral vectors
07/05/2001US20010006939 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
07/05/2001US20010006799 Histidine kinase polypeptides
07/05/2001US20010006798 Novel FtsL
07/05/2001US20010006792 Immunomodulatory properties
07/05/2001US20010006788 Complexing glycoprotein with antibodies; medical diagnosis
07/05/2001US20010006779 Isolated gene coding polypeptide
07/05/2001US20010006776 Methods for treatment of hiv and other infections using a t cell or viral activator and anti-retroviral combination therapy
07/05/2001US20010006641 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80
07/05/2001US20010006638 Treatment of immune suppression by infusing a dose of selected monoclonal antibodies that inhibit overproduction of lymphocyte function-related antigen 1 (lfa-1) on cd8cells
07/05/2001US20010006637 Rheumatoid arthritis remedy containing anti-il-8 antibody as active ingredient
07/05/2001CA2397710A1 Streptococcus pyogenes virulence genes and proteins and their use
07/05/2001CA2396029A1 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope
07/05/2001CA2395840A1 Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens
07/05/2001CA2395535A1 Method for the production of vitamin a
07/05/2001CA2395423A1 P. gingivalis antigenic composition
07/05/2001CA2395335A1 Genes identified as required for proliferation of e. coli
07/05/2001CA2395299A1 Method for producing 6-0-.alpha.-d-glucopyranosyl-d-sorbite
07/05/2001CA2395284A1 Inhibition of gsk-3.beta.
07/05/2001CA2395242A1 Composition for inhibiting macrophage activity
07/05/2001CA2395236A1 Basolateral sorting signal and inhibitors thereof
07/05/2001CA2395003A1 Dioxygenases catalyzing the asymetric cleavage of beta-carotene
07/05/2001CA2394880A1 Activation and inhibition of the immune system
07/05/2001CA2394295A1 Antibodies against plasma cells
07/05/2001CA2392703A1 Human heparanase-related polypeptide and nucleic acid
07/04/2001EP1112500A1 Tau as a marker for early cns damage
07/04/2001EP1112499A1 Method for detecting or quantifying basophils and eosinophils
07/04/2001EP1112497A1 Ykl-40 as a marker and prognostic indicator for cancers
07/04/2001EP1112496A2 Diagnostic method for detecting disturbances of the pancreas
07/04/2001EP1112495A2 Antibacterial disaccharide derivatives
07/04/2001EP1112382A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes
07/04/2001EP1112366A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
07/04/2001EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
07/04/2001EP1112364A2 Stomach polypeptide zsig28
07/04/2001EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system
07/04/2001EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization